SURGALIGN HOLDINGS, INC.: Nasdaq/NYSE listing notice — Surgalign receives Nasdaq deficiency letter for failing minimum stockholders' equity requirement

SURGALIGN HOLDINGS, INC.

Received deficiency letter on April 10, 2023 for non-compliance with $10M minimum stockholders' equity rule.
Must submit compliance plan by May 25, 2023; possible extension to October 7, 2023 if plan accepted.
Common stock continues trading on Nasdaq Global Select Market under SRGA; no immediate delisting.
No assurance of regaining compliance; failure could lead to delisting.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

SURGALIGN HOLDINGS, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5450(b)(1)(A), 5450(b)(2), 5450(b)(3)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5450(b)(1)(A), 5450(b)(2), 5450(b)(3)

Exact text from the filing

April 10, 2023, Surgalign Holdings, Inc. (the “Company”) received a deficiency letter (the “Letter”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum stockholders’ equity requirement for continued listing set forth in Nasdaq Listing Rule 5450(b)(1)(A). Nasdaq Listing Rule 5450(b)(1)(A) requires listed companies to maintain stockholders’ equity of at least $10,000,000 (the “Stockholders’ Equity Requirement”). The Staff further indicated that, as of the date of the Letter, the Co

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-23-099978

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.